Ceylon Hospitals Plc

  • Market Cap: Mid Cap
  • Industry: Hospital
  • ISIN: LK0338N00000
LKR
336.75
210.75 (167.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

Positive results in Dec 25

  • DEBT-EQUITY RATIO (HY) Lowest at 2.04 %
  • INVENTORY TURNOVER RATIO(HY) Highest at 4.98 times
  • INTEREST COVERAGE RATIO(Q) Highest at 1,646.92
2

With ROE of 6.85%, it has a fair valuation with a 0.00 Price to Book Value

3

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

LKR Million (Mid Cap)

stock-summary
P/E

0

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.01

stock-summary
Return on Equity

8.52%

stock-summary
Price to Book

0.00

Revenue and Profits:
Net Sales:
2,693 Million
(Quarterly Results - Dec 2025)
Net Profit:
245 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
169.4%
0%
169.4%
6 Months
195.39%
0%
195.39%
1 Year
178.88%
0%
178.88%
2 Years
179.55%
0%
179.55%
3 Years
191.9%
0%
191.9%
4 Years
227.34%
0%
227.34%
5 Years
344.07%
0%
344.07%

Ceylon Hospitals Plc for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
15.77%
EBIT Growth (5y)
15.86%
EBIT to Interest (avg)
16.20
Debt to EBITDA (avg)
0.47
Net Debt to Equity (avg)
0.17
Sales to Capital Employed (avg)
0.80
Tax Ratio
20.93%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
20.20%
ROE (avg)
8.82%

Valuation key factors

Factor
Value
P/E Ratio
Industry P/E
Price to Book Value
NA
EV to EBIT
0.18
EV to EBITDA
0.14
EV to Capital Employed
0.03
EV to Sales
0.04
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
18.45%
ROE (Latest)
6.85%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
No Trend
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -0.17% vs -2.02% in Sep 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Dec 2025 is -2.93% vs -18.07% in Sep 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Sep'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "2,693.40",
          "val2": "2,697.90",
          "chgp": "-0.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "788.70",
          "val2": "549.10",
          "chgp": "43.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "47.90",
          "val2": "48.80",
          "chgp": "-1.84%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "245.10",
          "val2": "252.50",
          "chgp": "-2.93%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "212.00%",
          "val2": "203.50%",
          "chgp": "0.85%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is 6.53% vs 15.78% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 59.98% vs -30.37% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "9,750.60",
          "val2": "9,152.60",
          "chgp": "6.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "2,762.40",
          "val2": "2,403.90",
          "chgp": "14.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "250.80",
          "val2": "144.70",
          "chgp": "73.32%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "202.60",
          "val2": "102.10",
          "chgp": "98.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "726.00",
          "val2": "453.80",
          "chgp": "59.98%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "220.30%",
          "val2": "200.70%",
          "chgp": "1.96%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - QoQstock-summary

Dec'25
Sep'25
Change(%)
Net Sales
2,693.40
2,697.90
-0.17%
Operating Profit (PBDIT) excl Other Income
788.70
549.10
43.64%
Interest
47.90
48.80
-1.84%
Exceptional Items
0.00
0.00
Consolidate Net Profit
245.10
252.50
-2.93%
Operating Profit Margin (Excl OI)
212.00%
203.50%
0.85%
USD in Million.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Dec 2025 is -0.17% vs -2.02% in Sep 2025

Direction Arrows
Consolidated Net Profit

QoQ Growth in quarter ended Dec 2025 is -2.93% vs -18.07% in Sep 2025

Annual Results Snapshot (Consolidated) - Mar'25stock-summary

Mar'25
Mar'24
Change(%)
Net Sales
9,750.60
9,152.60
6.53%
Operating Profit (PBDIT) excl Other Income
2,762.40
2,403.90
14.91%
Interest
250.80
144.70
73.32%
Exceptional Items
202.60
102.10
98.43%
Consolidate Net Profit
726.00
453.80
59.98%
Operating Profit Margin (Excl OI)
220.30%
200.70%
1.96%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2025 is 6.53% vs 15.78% in Mar 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 59.98% vs -30.37% in Mar 2024

stock-summaryCompany CV
About Ceylon Hospitals Plc stock-summary
stock-summary
Ceylon Hospitals Plc
Hospital
Ceylon Hospitals PLC is a holding company. The Company's Durdans cardiac center offers Cardiac Surgical Intensive Care Unit (CSICU) with over 10 beds, including facilities for pediatric cardiac surgical procedures, Heart Command Center, cardiac catheterization laboratory and a Heart Station. The Company's subsidiaries include Ceylon Hospitals PLC, which is engaged in providing healthcare services; Durdans Heart Surgical Centre (Pvt) Ltd., which is engaged in providing cardiac surgical operations and interventional procedures; Durdans Medical and Surgical Hospital (Pvt) Ltd., which is engaged in providing healthcare services, and Ceygen Biotech (Pvt) Ltd., which is engaged in supplying of molecular biological, biochemical, biotechnological reagents, kits, equipment and accessories for molecular diagnostics and research purpose.
Company Coordinates stock-summary
Company Details
No.03, Alfred Place, Colombo 03 , COLOMBO None : 03
stock-summary
Tel: 94 11 5410000
stock-summary
Registrar Details